glp 1 agonists for obesity What Are GLP-1 Weight Loss? Therapeutic benefits of glucagon-like peptide-1
Description
As the adverse health outcomes associated with obesity become increasingly publicized, the provider perspective on the condition has shifted, and providers across all specialties feel progressively more interested in writing off-label prescriptions for diabetes GLP-1s to treat obesity 3
Send Press Release
They believe this change will harm the productivity and well-being of thousands of people
Further efforts should be made to educate providers and the public at large about the effects of GLP-1 receptor agonists and guideline recommendations for their use
